The Steroid Profile of Adrenal Incidentalomas: Subtyping Subjects With High Cardiovascular Risk

被引:32
|
作者
Di Dalmazi, Guido [1 ,2 ]
Fanelli, Flaminia [1 ,2 ]
Zavatta, Guido [1 ,2 ]
Bitti, Silvia Ricci [1 ,2 ]
Mezzullo, Marco [1 ,2 ]
Repaci, Andrea [1 ,2 ]
Pelusi, Carla [1 ,2 ]
Gambineri, Alessandra [1 ,2 ]
Altieri, Paola [1 ,2 ]
Mosconi, Cristina [3 ]
Balacchi, Caterina [3 ]
Golfieri, Rita [3 ]
Cosentino, Eugenio Roberto [4 ]
Borghi, Claudio [4 ]
Vicennati, Valentina [1 ,2 ]
Pasquali, Renato [1 ,2 ]
Pagotto, Uberto [1 ,2 ]
机构
[1] Alma Mater Univ Bologna, S Orsola Malpighi Hosp, Endocrinol Unit, I-40138 Bologna, Italy
[2] Alma Mater Univ Bologna, S Orsola Malpighi Hosp, Ctr Appl Biomed Res, Dept Med & Surg Sci, I-40138 Bologna, Italy
[3] St Orsola Marcello Malpighi Hosp, Diagnost & Intervent Radiol Unit, Dept Diagnost & Prevent Med, I-40138 Bologna, Italy
[4] Alma Mater Univ Bologna, Hypertens Unit, Dept Med & Surg Sci, S Orsola Malpighi Hosp, I-40138 Bologna, Italy
来源
关键词
SUBCLINICAL CUSHINGS-SYNDROME; INCREASED MORTALITY; MASS-SPECTROMETRY; BLOOD-PRESSURE; CORTISOL; HYPERCORTISOLISM; HYPERTENSION; MANAGEMENT; DIAGNOSIS;
D O I
10.1210/jc.2019-00365
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context: Steroid profiling by mass spectrometry has shown implications for diagnosis and subtyping of adrenal tumors. Objectives: To investigate steroid profiles and their cardiovascular correlates in a large cohort of patients with nonsecreting (NS) adrenal incidentalomas and autonomous cortisol secretion (ACS). Design: Cohort study. Setting: University hospital. Patients: Patients (n = 302) with incidentally discovered adrenal masses, divided into unilateral adenoma and hyperplasia with ACS (n = 46 and n = 52, respectively) and NS (n = 120 and n = 84, respectively). Post-dexamethasone suppression test (DST) cortisol <50 or >50 nmol/L defined NS and ACS, respectively. Intervention: Analysis of 10-steroid panel by liquid chromatography-tandem mass spectrometry (LC-MS/MS) and clinical data (mean follow-up 39 months). Main Outcome Measures: Difference in baseline and post-DST steroid profiles between groups. Correlation with cardiovascular profile. Results: Patients with unilateral adenomas and ACS showed higher cortisol, 11-deoxycortisol, and corticosterone and lower dehydroepiandrosterone than those with NS adenomas. Patients with ACS hyperplasia showed higher cortisol and lower androgens in women than those with NS. Patients with ACS had reduced suppression of post-DST cortisol, 11-deoxycortisol, and corticosterone, irrespective of adrenal morphology. Post-DST cortisol and corticosterone were associated with higher prevalence of severe/resistant hypertension. Patients with ACS unilateral adenomas showed higher incidence of worsening of hypertensive disease and novel cardiovascular events than those with NS, with post-DST cortisol [hazard ratio (HR) 1.02; 95% CI, 1.01 to 1.03; P < 0.001] and baseline corticosterone (HR 1.06; 95% CI, 1.01 to 1.12; P = 0.031) among the main predictors. Conclusions: Patients with adrenal incidentalomas showed different steroid profiles, depending on functional status and adrenal morphology, with implications for their cardiovascular status.
引用
收藏
页码:5519 / 5528
页数:10
相关论文
共 50 条
  • [1] The Etiological Profile of Adrenal Incidentalomas
    Lahmamssi, Fatima-Zahra
    Saadaoui, Loubna
    Aynaou, Hayat
    Salhi, Houda
    El Ouahabi, Hanan
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [2] Steroid secretions in patients with adrenal incidentalomas
    Reincke, M
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (10): : 3811 - 3812
  • [3] CARDIOVASCULAR RISK AND CORTISOL SECRETION IN ADRENAL INCIDENTALOMAS: A RETROSPECTIVE STUDY
    Olmati, F.
    Petramala, L.
    Bisogni, V.
    Mezzadri, M.
    Russo, R.
    Saracino, V.
    Concistre, A.
    Bonvicini, M.
    Oliviero, G.
    Iannucci, G.
    De Toma, G.
    Letizia, C.
    [J]. JOURNAL OF HYPERTENSION, 2019, 37 : E30 - E30
  • [4] Adrenal steroid metabolites and bone status in patients with adrenal incidentalomas and hypercortisolism
    Nakao, Hiroshi
    Yokomoto-Umakoshi, Maki
    Nakatani, Kohta
    Umakoshi, Hironobu
    Ogata, Masatoshi
    Fukumoto, Tazuru
    Kaneko, Hiroki
    Iwahashi, Norifusa
    Fujita, Masamichi
    Ogasawara, Tatsuki
    Matsuda, Yayoi
    Sakamoto, Ryuichi
    Izumi, Yoshihiro
    Bamba, Takeshi
    Ogawa, Yoshihiro
    [J]. EBIOMEDICINE, 2023, 95
  • [5] Low catestatin as a risk factor for cardiovascular disease - assessment in patients with adrenal incidentalomas
    Zalewska, Ewa
    Kmiec, Piotr
    Sobolewski, Jakub
    Koprowski, Andrzej
    Sworczak, Krzysztof
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [6] Assessment of subclinical cardiovascular alterations in nonfunctioning adrenal incidentalomas
    Can, Bulent
    Ozer, Pelin Karaca
    Can, Busra
    Caklili, Ozge Telci
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (03) : 677 - 682
  • [7] Natural course of benign adrenal incidentalomas in subjects with extra-adrenal malignancy
    Serkan Yener
    Senem Ertilav
    Mustafa Secil
    Baris Akinci
    Tevfik Demir
    Abdurrahman Comlekci
    Sena Yesil
    [J]. Endocrine, 2009, 36 : 135 - 140
  • [8] Natural course of benign adrenal incidentalomas in subjects with extra-adrenal malignancy
    Yener, Serkan
    Ertilav, Senem
    Secil, Mustafa
    Akinci, Baris
    Demir, Tevfik
    Comlekci, Abdurrahman
    Yesil, Sena
    [J]. ENDOCRINE, 2009, 36 (01): : 135 - 140
  • [9] Characterisation of the urinary steroid profile of patients with nonfunctioning adrenal incidentalomas: A matched controlled cross-sectional study
    Araujo-Castro, Marta
    Casals, Gregori
    Hanzu, Felicia A.
    Pascual-Corrales, Eider
    Cano, Ana M. Garcia
    Lanza, Val F.
    del Rey Mejias, Angel Luis
    Marchan, Marta
    Escobar-Morreale, Hector F.
    Valderrabano, Pablo
    [J]. CLINICAL ENDOCRINOLOGY, 2023, 98 (02) : 165 - 176
  • [10] The relationship between adrenal incidentalomas and mortality risk
    Michio Taya
    Viktoriya Paroder
    Eran Bellin
    Linda B. Haramati
    [J]. European Radiology, 2019, 29 : 6245 - 6255